Andreas completed Navigo’s management team in April 2020 as CFO. Andreas has over 25 year’s experience in banking, consulting and finance; thereof 20 years as CFO/finance consultant for Life Sciences Companies (e.g. Direvo, 4-Antibody, AYOXXA). He negotiated and executed several financing rounds, collaboration deals and M&A-transactions (e.g. sale of Direvo Biotech AG to Bayer for 210m EUR, sale of 4-Antibody AG, CH to Agenus Inc., USA) and is a hands-on expert in financing, financial management and controlling. Andreas is co-founder, investor and member of the advisory board of several start-up and growth companies in the field of Biotech/Medtech and e-commerce in Europe and Asia. He studied Business Administration at University of Cologne (Diplom-Kfm) and at Penn State University , PA, USA.